Results 151 to 160 of about 66,132 (287)
Microglial GPR35 Ameliorates Epileptogenesis and Neuroinflammation via PDGFA Domain 2 Signaling
Activation of microglial G protein–coupled receptor 35 (GPR35) by L‐kynurenic acid (L‐Kyna) initiates a platelet‐derived growth factor A (PDGFA)–dependent phosphoinositide 3‐kinase–protein kinase B (PI3K–AKT) signaling cascade that dampens hippocampal neuroinflammation, thereby restraining epileptogenesis, lowering seizure susceptibility, and ...
Qi Wang +17 more
wiley +1 more source
Direct evidence of acid-driven protein desolvation. [PDF]
Hamdi F +9 more
europepmc +1 more source
Glutamate inputs send prediction error of reward, but not negative value of aversive stimuli, to dopamine neurons [PDF]
Ryunosuke Amo +2 more
openalex +1 more source
Inspired by antibody‐antigen binding, this study develops an unprecedented immunoaffinity‐mimetic assembly strategy, with Peptide‐AptCD63 conjugates acting as antibody surrogates binding CD63 epitopes on mesenchymal stem cell‐derived exosomes. This creates a hierarchical microstructure intended to synergistically integrate antioxidative and anti ...
Dantong Zheng +8 more
wiley +1 more source
Structural basis of drug recognition by human MATE1 transporter. [PDF]
Romane K +8 more
europepmc +1 more source
Arginine 447 Plays a Pivotal Role in Substrate Interactions in a Neuronal Glutamate Transporter
Annie Bendahan +4 more
openalex +1 more source
This study delineates macrophage heterogeneity along the acute kidney injury to chronic kidney disease transition. Single‐cell RNA sequencing reveals a TRAP5+ scar‐associated macrophage subset driven by Spp1–Cd44 signaling and mitochondrial metabolic reprogramming.
Chenxi Wang +13 more
wiley +1 more source
Identification, characterization, and structure-activity relationship of the ASIC3-selective peptide WRPRFa. [PDF]
Chien C +4 more
europepmc +1 more source
Glutamate inhibition in MS: The neuroprotective properties of riluzole
Joep Killestein +2 more
openalex +2 more sources
Triple‐negative breast cancer has a poor prognosis. Xanthatin directly targets and degrades CISD1, triggering ferroptosis through iron dysregulation. The concurrently activated mitophagy synergistically amplifies ferroptotic cell death. Xanthatin also demonstrates potent in vivo anti‐tumor efficacy with minimal toxicity, highlighting its therapeutic ...
Qinwen Liu +9 more
wiley +1 more source

